• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Rachima leaving before cutbacks/ Reorganization





Sooner than you think. 3rd ate. Announced, affective by year end.
It should not surprise anyone. 80% of offices are shut down to reps, with majority not opening back up to old ways.